A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis

Archives of Internal Medicine

Volumn 157, Issue 18, 1997, Pages 2101-2108

  Krnic Barrie, Sanja ^a   O'Connor, Carolyn Riester ^b,c   Looney, Stephen W ^a   Pierangdi, Silvia S ^d   Harris, E Nigel ^d,e  

^a University of Louisville School of Medicine   (United States)

^b Department of Anesthesiology   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

^e Warehouse School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUPUS ANTICOAGULANT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL FEATURE; DISEASE CONTROL; DISEASE PREDISPOSITION; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SMOKING HABIT; STATISTICAL ANALYSIS; THROMBOSIS; VEIN THROMBOSIS;

EID: 0030924102     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.18.2101     Document Type: Article

References (12)

1. Harris EN, Pierangeli SS. Antiphospholipid antibodies and the antiphospholipid syndrome. Springer Semin Immunopathol. 1994;16:223-245.
2. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am. 1994;20:45-60.
3. Glueck HI, Kant KS, Weiss MA. Thrombosis in systemic lupus erythematosus: relation to the presence of circulating anticoagulants. Arch Intern Med. 1985; 145:1389-1395.
4. Elias M, Eldor A. Thromboembolism in patients with the 'lupus-like' circulating anticoagulant. Arch Intern Med. 1984;144:510-543.
5. Asherson RA, Khamashta MA, Gil AG, et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid antibody syndrome. Am J Med. 1989;86:391-399.
6. Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies and cerebral ischemia. Stroke. 1989;20:225-229.
7. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology. 1990;40:1190-1196.
8. Coull BM, Bourdette DN, Goodnight SH, Briley DP, Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke. 1987; 18:1107-1112.
9. Levine SR, Brey RL, Joseph CLM, Havstad S. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke. 1992;23(suppl):129-132.
10. The Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke. 1990;21:1268-1273.
11. Silver RM, Draper MJ, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol. 1994;83:372-377.
12. Asherson RA, Chan JKH, Harris EN, Gharavi AK, Hughes GRV. Anticardiolipin antibody, recurrent thrombosis and warfarin withdrawal. Ann Rheum Dis. 1985; 44:823-825.